Franklin Resources, Inc. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-27 12:58 pm Purchase |
2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,137,567 6.100% |
125,519 (+3.13%) |
Filing |
| 2024-10-31 12:51 pm Sale |
2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,012,048 7.500% |
-628,603 (-13.55%) |
Filing |
| 2024-02-06 10:55 am Purchase |
2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,640,651 9.500% |
510,514 (+12.36%) |
Filing |
| 2023-09-11 11:15 am Sale |
2023-08-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,130,137 11.800% |
-1,644,372 (-28.48%) |
Filing |
| 2023-01-31 11:44 am Purchase |
2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
5,774,509 16.900% |
827,344 (+16.72%) |
Filing |
| 2022-02-03 2:02 pm Purchase |
2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,947,165 14.600% |
3,533,218 (+249.88%) |
Filing |
| 2021-02-01 2:18 pm Purchase |
2020-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
1,413,947 7.800% |
1,413,947 (New Position) |
Filing |